Search Results (949)
Documents on Technology And Science, Biotech & Life Sciences, Government, Technology & Science
Show: results per page
|Space Weather Strategy and Action Plan|
Sutherland Asbill Brennan LLP;
November 10, 2015, previously published on November 9, 2015Owners and operators of critical infrastructure are encouraged to coordinate with electric power providers to ensure response and recovery following outages resulting from space-weather events. Space weather refers to variations in the space environment between the sun and earth, such as...
|Smartphone is Key to Preventing ATM Thefts|
Peter Y. Fu, Michael L. Salad; Cooper Levenson, P.A.;
October 22, 2015, previously published on October 9, 2015Theft of personal identification numbers (PINs) has become so common that it is usually only reported in the news if it occurs in your local area, as it did in our neighboring town of Margate, New Jersey in September 2015 (http://bit.ly/1huJcxB).
|ASRC Announces Changes to NAD and NARB Procedures Following Working Group Recommendations|
Loeb Loeb LLP;
October 13, 2015, previously published on September 2015The Advertising Self-Regulatory Council board has announced changes to the adjudicatory processes of the National Advertising Division and the National Advertising Review Board. The changes, announced at the NAD's annual conference on September 29, 2015, adopt a number of recommendations made by a...
|FDA Indicates Shared Nonproprietary Names Not Appropriate for All Biological Products, Including Biosimilars|
Edgar J. Asebey, Maureen Bennett, Colleen Heisey, Janet M. McNicholas, Christian Paul; Jones Day;
September 11, 2015, previously published on September 2015On August 28, 2015, the U.S. Food & Drug Administration ("FDA") released a draft guidance document describing its current position on biological product nonproprietary naming, including the need for biological products to bear a nonproprietary name to which is attached an...
|DC Circuit Court Upholds Federal Ban On Campaign Contributions - What’s Next for Politically Active Government Contractors?|
William H. Minor; DLA Piper (Canada) LLP;
September 10, 2015, previously published on July 14, 2015A unanimous federal appeals court in Washington, DC has upheld a long-standing ban on federal campaign contributions by government contractors.
|Generating Life Sciences Brand Names: 5 Key Tips|
Virginia Wolk Marino, Christina L. Martini; DLA Piper (Canada) LLP;
September 10, 2015, previously published on August 25, 2015In the challenging and complex world of life sciences product development, choosing a brand that survives the US Patent and Trademark Office and US Food and Drug Administration clearance processes is critical. Brand names in this industry are subject to heightened scrutiny because confusingly...
|CON Laws, COPAs and the FTC: 7 Antitrust Points for the Healthcare Sector|
Steven Levitsky, Lesli C. sposito; DLA Piper (Canada) LLP;
September 10, 2015, previously published on August 6, 2015The Federal Trade Commission is on a roll in its attack on what it considers anti-competitive effects in the healthcare industry. And that roll has consistently involved challenging activity that once appeared to be protected by state laws.
|China Adopts the New National Security Law - A Top Legislative Effort to Control Cybersecurity|
Yunzhu Huang, Scott Thiel; DLA Piper (Canada) LLP;
September 10, 2015, previously published on July 2, 2015On 1 July 2015, the Standing Committee of the National People's Congress, China's top legislature, approved the new National Security Law of the People's Republic of China (the "New Law") which became effective on the same day. This New Law is very high-level in its nature, covering a...
|Student Data Protection in an Era of Education Technology Innovation|
Katherine D. Brodie, Michelle Hon Donovan, Alison Haddock Hutton; Duane Morris LLP;
September 7, 2015, previously published on August 7, 2015Consensus regarding how and whether to increase federal mandates and penalties concerning protection of PII has not yet been reached, but awareness exists that student PII, whether for K-12 students or older, is becoming increasingly vulnerable to unauthorized disclosure or misuse, in particular...
|Court Prohibits FDA from Bringing Charges against Drugmaker Amarin for Promoting Fish Oil Drug for Off-Label Uses|
Scott S. Liebman; Loeb & Loeb LLP;
September 1, 2015, previously published on August 2015A New York federal judge granted Amarin’s bid for “preliminary relief,” allowing the drugmaker to promote its Vascepa pill for off-label use without the threat of an FDA misbranded action, as long as its communications are truthful and nonmisleading.